Hard gelatin and hypromellose (HPMC) capsules: Estimation of rupture time by real-time dissolution spectroscopy

Drug Development and Industrial Pharmacy

Volumn 33, Issue 1, 2007, Pages 27-34

  El Malah, Yasser ^a   Nazzal, Sami ^a   Bottom, Carey B ^b  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b Business Development and Technical Affairs   (United States)

Author keywords

Dissolution; Dosage forms; Hard gelatin capsules; HPMC capsules; Hypromellose capsules; Real time spectroscopy

Indexed keywords

GELATIN; HYDROXYPROPYLMETHYLCELLULOSE; LABRASOL; QUALI V; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ARTICLE; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; FIBER OPTICS; LIGHT SCATTERING; MOLECULAR PROBE; REAL TIME DISSOLUTION SPECTROSCOPY; SPECTROSCOPY; STATISTICAL ANALYSIS; TEMPERATURE; VALIDATION PROCESS;

CAPSULES; GELATIN; HYDROGEN-ION CONCENTRATION; METHYLCELLULOSE; SOLUBILITY; SPECTRUM ANALYSIS; TIME FACTORS;

EID: 33845919075     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600685183     Document Type: Article

References (17)

1. Alderman, D. A. (1984). A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int. J. Pharm. Technol. Prod. Manufacture, 5, 1-9.
2. Bonferoni, M. C., Rossi, S., Ferrari, F., Stavik, E., Pena-Romero, A., & Caramella, C. (2001). Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes. AAPS PharmSciTech, 1(2): E15.
3. Carstensen, J. T. & Rhodes, C. T. (1993). Pellicle formation in gelatin capsules. Drug Dev. Ind. Pharm. 19, 2709-2712.
4. Chiwele, I., Jones, B. E., & Podczeck, F. (2000). The shell dissolution of various empty hard capsule. Chem. Pharm. Bull., 48(7), 951-956.
5. Digenes, G. A., Gold, T. B., & Shah, V. P. (1994). Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J. Pharm. Sci., 83, 915-921.
6. Elliott, G. R. (1972) Sodium bicarbonate and oral tetracycline. Clin. Pharmacol. Therapeutics, 13, 459.
7. Harwood, R. J. & Johnson, J. L. (1994). In Handbook of Pharmaceutical Excipients, (2nd Ed.); Wade A., & Weller P. 1. Ed.; The Pharmaceutical Press: London; 229-232.
8. Hüttenrauch, R. (1971). Importance of the ion strength in the degradation rapidity of gelatin capsules. Pharmazie, 26, 107-108.
9. Jones, B. E. (1972). Disintegration of hard gelatin capsule. Acta Pharm. Suec., 9, 261-263.
10. Jones, B. E. (1987). The history of the gelatin capsule. In Hard Capsules. Development and Technology; Ridgway, K., Ed.; The Pharmaceutical Press: London; 1-12.
11. Kavanagh, N. & Corrigan, O. I. (2004). Swelling and erosion properties of hydroxypropyl methylcellulose (Hypromellose) matrices-influence of agitation rate and dissolution medium composition. Int. J. Pharm., 279, 141-152.
12. Matsuura, S. & Yamamoto, T. (1993). New hard capsules prepared from water soluble cellulose derivative. Yakuzaigaku, 53(2), 135-140.
13. Mitchell, K., Ford, J. L., Armstrong, D. J., Elliott, P. N. C., Rostron, C., & Hogan, J. E. (1990). The influence of additives on the cloud point, disintegration and dissolution of hydroxypropyl methylcellulose gels and matrix tablets. Int. J. Pharm., 66, 233-242.
14. Nazzal, S., Smalyukh, I. I., Lavrentovich, O. D., & Khan, M. A. (2002). Preparation and in-vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of Ubiquinone: Mechanism and progress of emulsion formation. International Journal of Pharmaceutics, 235, 247-265.
15. Nazzal, S. & Wang, Y. (2001). Characterization of soft gelatin capsules by thermal analysis. Int. J. Pharm., 230(1-2), 35-45.
16. Tochio, S., Nagata, S., & Yamashita, S. (2002). The influence of the composition of test fluids on dissolution from HPMC capsules. AAPS PharmSci., 4(4), abstract W4340.
17. Willis, R. C. (2004). Government legislation is prompting drug companies to reevaluate their manufacturing processes. Modern Drug Discovery, 12, 29-32.